DelveInsight's "Acute Pancreatitis Market Insights, Epidemiology, and Market Forecast 2030" reports deliver an in-depth understanding of the disease, historical and forecasted epidemiology, the pipeline insight as well as the Acute Pancreatitis market size and shares analysis in the seven major markets (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. The report also covers emerging drugs, current treatment practices, Acute Pancreatitis market shares of the individual therapies, a detailed current Acute Pancreatitis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the market.
Acute pancreatitis (AP) is characterized by inflammation of the exocrine pancreas which occurs as a result of autodigestion of the pancreas by pancreatic enzymes. AP is associated with acinar cell injury and both a local and systemic inflammatory response. The incidence of acute pancreatitis has been increasing worldwide, but the major etiologies remain gallstones and alcohol. While most cases of acute pancreatitis are mild, the challenge remains in managing the severe cases and the complications associated with acute pancreatitis. As no curative therapy is currently available for acute pancreatitis, early treatment consists of supportive care which includes adequate fluid resuscitation and pain management. Improvement in diagnostic methods, increase in research initiatives, and a better understanding of disease pathology will lead to the development of novel therapeutic approaches.
Acute Pancreatitis Market Key Facts
- According to Delveinsight’s estimates, the total diagnosed incident population of Acute Pancreatitis in the 7MM was 502,390 in 2020.
- The estimates suggest that the gender-based incidence varied in the 7MM with the male incident cases higher in the United Kingdom, Japan, and Germany, whereas in the United States the female incident cases were higher.
- As per a study by Vege et al., the reported annual incidence of acute pancreatitis in the United States ranges from 4.9 to 35 per 100,000 population.
- As per a study by Vege et al., 2019, Gallstones (including microlithiasis) are the most common cause of acute pancreatitis accounting for 40 to 70 percent of cases.
Acute Pancreatitis Market Share Analysis
The market size of Acute Pancreatitis is anticipated to increase during the study period owing to the launch of upcoming therapies, changing lifestyles, increasing disposable income, etc. The increasing awareness of the disease and rising incidence of Acute Pancreatitis will also fuel the market growth.
The Acute Pancreatitis market analysis section of the report helps to understand the current and forecasted Acute Pancreatitis market trends and growth by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers.
The report gives complete detail of Acute Pancreatitis market size and shares of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Acute Pancreatitis Epidemiology Forecast
The Acute Pancreatitis epidemiology section covers insights about historical and current Acute Pancreatitis patient pool and forecasted trends for every seven major countries (i.e., the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Acute Pancreatitis Epidemiology Segmentation -
- Diagnosed Incident Cases of Acute Pancreatitis
- Diagnosed Incidence of Acute Pancreatitis by Etiology
- Diagnosed Incidence of Acute Pancreatitis by Severity
- Diagnosed Incidence of Acute Pancreatitis by Gender
It helps to recognize the causes of current and forecasted Acute Pancreatitis Epidemiology trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends, along with assumptions undertaken.
Acute Pancreatitis Therapeutics Market
The management of acute pancreatitis depends on the severity of the disease and the concomitant complications. Treatment for acute pancreatitis aims to help control the condition and manage any symptoms. This usually involves admission to the hospital. One may be given fluids directly into a vein (intravenous fluids), pain relief, liquid food through a tube in the stomach, and oxygen through tubes in the nose. Currently, the effective management of Acute Pancreatitis mainly involves the usage of symptomatic and supportive therapies including Pain Medications, Nutritional Support, Hydration Therapy, Pancreatic Enzymes such as Somatostatin, and antibiotics. There are no approved therapies in the market for the treatment of Acute Pancreatitis at present, thereby leading to a largely untapped market in the offering for major players to capitalize on.
For more details, visit: Acute Pancreatitis Market Share